Serial #85196161
DEAD

Serial Number

85196161

Owner

FUJIFILM CORPORATION

Attorney

Doreen L Costa

Filing Date

Dec 13, 2010

Add to watchlist:

No watchlists yet
View on USPTO

Serial #85196161 Trademark

Serial Number: 85196161 • Registration: 4270500

Serial #85196161 is a trademark filed by FUJIFILM CORPORATION on December 13, 2010. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

FUJIFILM CORPORATION (515 trademarks)

26-30, NISHIAZABU 2-CHOME, MINATO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

December 13, 2010

Registration Date

January 8, 2013

Published for Opposition

October 2, 2012

Cancellation Date

August 9, 2019

Goods & Services

Pharmaceutical preparations, namely, central nervous system agents, peripheral nervous system agents, sensory organ agents, miscellaneous nervous system and sensory organ agents, cardiovascular agents, respiratory organ agents, digestive organ agents, hormones, urogenital and anal organ agents, epidermides, dental preparations, miscellaneous organ agents, vitamins, nutrients, tonics, blood and body fluid agents, dialysis agents, miscellaneous metabolism agents, cellular function activating agents, antineoplastics, radioactive drugs, allergic agents, miscellaneous cellular function agents, crude drugs, antibiotics, chemotherapeutics, biological preparations, parasitics (systemic), pathogenic organism agents, dispensing medicines, intracorporeal diagnostic agents for medical purposes, extracorporeal diagnostic agents for medical purposes, prescription alkaloidal narcotics, prescription non-alkaloidal narcotics, and traditional Chinese medicines, public health agents and non-main therapeutic purpose agents for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, circulatory system, respiratory system, digestive system, endocrine system, urogenital and anal organs, epidermis, mouth, blood system, liver, kidney, metabolic system and immune system; sanitary preparations for medical use; oiled paper for medical purposes; drug delivery agents in the form of pharmaceutical wafers and gelatin-starch films for providing controlled release of the active ingredients for a wide variety of pharmaceuticals; gauze; empty capsules for pharmaceuticals; eye patches for medical purposes; ear bandages for dressings; sanitary pads; menstruation tampons; sanitary napkins; sanitary panties; cotton for medical purposes; bandages for skin wounds, medical plasters, medical dressings; medical dressing in liquid form, medical dressings containing collodion for pharmaceutical purposes; breast-nursing pads; dental composite materials; incontinence diapers; dietetic lactic sugar for medical use; powdered milk for infants; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing astaxanthin as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing ceramide as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing vitamin E as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing lycopene as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing vitamin C as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing selenium yeast as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing zinc yeast as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing concentrated salacia extract powder as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing onion integument extract as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing chitosan as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing apple polyphenol as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing tea catechin as a principal ingredient; nutritional supplements in tablet form, capsule form, soft capsule form, fine powder form, powder form, granule form, pill form, liquid form, paste form, gel form, and solid form containing chromium yeast as a principal ingredient

Cosmetics; non-medicated toiletries; soaps; detergents for household use; dentifrices, fragrances and perfumery, incenses; false nails; false eyelashes; anti-static preparations for household purposes; de-greasing preparations for household purposes; rust removing preparations; stain removing preparations; fabric softeners for laundry use; laundry bleaches

Retail and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services for cosmetics and toiletries; retail and wholesale store services for processed foods; advertising for others via websites on the Internet; providing businesses information through websites on the Internet; providing consumer products information through websites on the Internet; retail and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies through websites on the Internet; retail and wholesale store services for cosmetics and toiletries through websites on the Internet; retail and wholesale store services for processed foods through websites on the Internet

Chemical powders and emulsifiers for use in the manufacture of health foods and supplements; chemical powders and emulsifiers for use in the manufacture of cosmetics; chemicals for use in the manufacture of pharmaceutical preparations; chemical preparations for general industrial manufacturing

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 9, 2019 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 8, 2018 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 8, 2013 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Dec 5, 2012 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 5, 2012 AITU
NOTICE OF ALLOWANCE CANCELLED
Dec 3, 2012 IUCN
TEAS POST PUBLICATION AMENDMENT RECEIVED
Dec 3, 2012 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 27, 2012 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 2, 2012 NPUB
PUBLISHED FOR OPPOSITION
Oct 2, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 12, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 28, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 1, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 31, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 31, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 31, 2012 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 9, 2012 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jun 25, 2012 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 12, 2012 PREV
EXPARTE APPEAL TERMINATED
Jun 12, 2012 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2012 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 19, 2012 ERFR
EX PARTE APPEAL-INSTITUTED
Apr 19, 2012 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Apr 19, 2012 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Apr 19, 2012 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 19, 2011 GNFN
FINAL REFUSAL E-MAILED
Oct 19, 2011 GNFR
FINAL REFUSAL WRITTEN
Oct 19, 2011 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 27, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2011 CRFA
ASSIGNED TO LIE
Sep 15, 2011 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 13, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 14, 2011 GNRN
NON-FINAL ACTION E-MAILED
Mar 14, 2011 GNRT
NON-FINAL ACTION WRITTEN
Mar 14, 2011 CNRT
ASSIGNED TO EXAMINER
Mar 10, 2011 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Dec 17, 2010 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 16, 2010 NWOS
NEW APPLICATION ENTERED
Dec 16, 2010 NWAP